What is the rationale for growth hormone therapy in Turner's syndrome?

This publication has 15 references indexed in Scilit:

• Reduced Growth Hormone Secretion in Turner Syndrome: Is Body Weight a Key Factor?
  Hormone Research, 1994
• Assessment of growth hormone (GH) axis in Turner's syndrome using 24- hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation
  Journal of Clinical Endocrinology & Metabolism, 1992
• Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome
  The Journal of Pediatrics, 1992
• GH Assessment and Three Years’ hGH Therapy in Girls with Turner Syndrome
  Hormone Research, 1992
• Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
  Archives of Disease in Childhood, 1991
• Growth Hormone Secretion in Pubertal Age Patients with Turner's Syndrome
  Journal of Clinical Endocrinology & Metabolism, 1990
• Possible Mechanism for the Growth Retardation in Turner's Syndrome
  Acta Paediatrica, 1989
• NEUROENDOCRINE FUNCTION IN OBESITY
  Clinical Endocrinology, 1988
• Growth hormone, somatomedin levels and growth regulation in Turner's syndrome
  Acta Endocrinologica, 1987
• Growth hormone secretory dynamics in Turner syndrome
  The Journal of Pediatrics, 1985